The SALL4 expression level in all of the CR groups was lower than that in their corresponding groups i.e., AML vs. AML-CR (p< 0.0001), M2 vs. M2-CR (p=0.017), M3 vs. M3-CR (p=0.007) and CML vs. CML-CR (p=0.011) (Figures 1 and 2). Here, SALL4 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.